Cargando…
Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold
Artificial intelligence (AI) is a broad term referring to any automated systems that need ‘intelligence’ to carry out specific tasks. During the last decade, AI-based techniques have been gaining popularity in a vast range of biomedical fields, including the cardiovascular setting. Indeed, the disse...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947926/ https://www.ncbi.nlm.nih.gov/pubmed/36845218 http://dx.doi.org/10.15420/ecr.2022.11 |
_version_ | 1784892667310637056 |
---|---|
author | Chiarito, Mauro Luceri, Luca Oliva, Angelo Stefanini, Giulio Condorelli, Gianluigi |
author_facet | Chiarito, Mauro Luceri, Luca Oliva, Angelo Stefanini, Giulio Condorelli, Gianluigi |
author_sort | Chiarito, Mauro |
collection | PubMed |
description | Artificial intelligence (AI) is a broad term referring to any automated systems that need ‘intelligence’ to carry out specific tasks. During the last decade, AI-based techniques have been gaining popularity in a vast range of biomedical fields, including the cardiovascular setting. Indeed, the dissemination of cardiovascular risk factors and the better prognosis of patients experiencing cardiovascular events resulted in an increase in the prevalence of cardiovascular disease (CVD), eliciting the need for precise identification of patients at increased risk for development and progression of CVD. AI-based predictive models may overcome some of the limitations that hinder the performance of classic regression models. Nonetheless, the successful application of AI in this field requires knowledge of the potential pitfalls of the AI techniques, to guarantee their safe and effective use in daily clinical practice. The aim of the present review is to summarise the pros and cons of different AI methods and their potential application in the cardiovascular field, with a focus on the development of predictive models and risk assessment tools. |
format | Online Article Text |
id | pubmed-9947926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Radcliffe Cardiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-99479262023-02-24 Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold Chiarito, Mauro Luceri, Luca Oliva, Angelo Stefanini, Giulio Condorelli, Gianluigi Eur Cardiol Risk Stratification and Biomarkers Artificial intelligence (AI) is a broad term referring to any automated systems that need ‘intelligence’ to carry out specific tasks. During the last decade, AI-based techniques have been gaining popularity in a vast range of biomedical fields, including the cardiovascular setting. Indeed, the dissemination of cardiovascular risk factors and the better prognosis of patients experiencing cardiovascular events resulted in an increase in the prevalence of cardiovascular disease (CVD), eliciting the need for precise identification of patients at increased risk for development and progression of CVD. AI-based predictive models may overcome some of the limitations that hinder the performance of classic regression models. Nonetheless, the successful application of AI in this field requires knowledge of the potential pitfalls of the AI techniques, to guarantee their safe and effective use in daily clinical practice. The aim of the present review is to summarise the pros and cons of different AI methods and their potential application in the cardiovascular field, with a focus on the development of predictive models and risk assessment tools. Radcliffe Cardiology 2022-12-20 /pmc/articles/PMC9947926/ /pubmed/36845218 http://dx.doi.org/10.15420/ecr.2022.11 Text en Copyright © 2022, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly. |
spellingShingle | Risk Stratification and Biomarkers Chiarito, Mauro Luceri, Luca Oliva, Angelo Stefanini, Giulio Condorelli, Gianluigi Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold |
title | Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold |
title_full | Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold |
title_fullStr | Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold |
title_full_unstemmed | Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold |
title_short | Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold |
title_sort | artificial intelligence and cardiovascular risk prediction: all that glitters is not gold |
topic | Risk Stratification and Biomarkers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947926/ https://www.ncbi.nlm.nih.gov/pubmed/36845218 http://dx.doi.org/10.15420/ecr.2022.11 |
work_keys_str_mv | AT chiaritomauro artificialintelligenceandcardiovascularriskpredictionallthatglittersisnotgold AT luceriluca artificialintelligenceandcardiovascularriskpredictionallthatglittersisnotgold AT olivaangelo artificialintelligenceandcardiovascularriskpredictionallthatglittersisnotgold AT stefaninigiulio artificialintelligenceandcardiovascularriskpredictionallthatglittersisnotgold AT condorelligianluigi artificialintelligenceandcardiovascularriskpredictionallthatglittersisnotgold |